The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind Wegovy, announced Wednesday that it has lowered its monthly cost by 23%. The new price — $499 per month — takes effect immediately. The… read on > read on >
Getting essential vitamins and minerals during pregnancy can help a woman maintain healthy blood pressure into middle age, new research suggests. High levels of the minerals copper and manganese in pregnant women were associated with lower blood pressure decades later, as well as a reduced risk of high blood pressure, researchers reported. Higher levels of… read on > read on >
It’s a cook’s maxim that everything’s better with butter. Except your health, a new study suggests. People who eat loads of butter have a higher risk of premature death, while those who use mostly plant-based oils like canola or olive oil have a lower-than-average risk, researchers found. What’s more, swapping butter out for plant-based oils… read on > read on >
.jpg)
The five-second intravenous bolus offers faster, simpler administration than Activase read on >
Florida’s insurance regulator is demanding detailed prescription data on millions of patients, raising alarms over patient privacy. In January, the Florida Office of Insurance Regulation asked pharmacy benefit managers — companies that manage prescription drug plans — to hand over highly personal data about prescriptions filled in the state last year. The data request includes… read on > read on >
More than half of adults and a third of children and teens worldwide will be overweight or obese by 2050, a comprehensive global analysis has concluded. Overweight and obesity rates in adults, children and teens more than doubled over the past three decades, afflicting 2.1 billion adults and 493 million young people with excess weight,… read on > read on >
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an injectable asthma drug, new clinical trial findings report. In all, 36% of children treated with omalizumab (Xolair) for a year successfully ate full servings of allergy-triggering foods, according to phase 2 trial results presented… read on > read on >
GLP-1 drugs like Ozempic/Wegovy don’t increase a person’s risk of suicidal actions or thoughts, a new study has concluded. Earlier research had potentially linked these drugs — which are used to treat type 2 diabetes and obesity — with suicidal thoughts and self-harm, researchers added. But the new study found no such association after following… read on > read on >
Utah may become the first state in the U.S. to ban fluoride in public water statewide, a move that would override local decisions on whether to add the cavity-fighting mineral to drinking water. The bill now awaits the signature of Gov. Spencer Cox, who has not said whether he will approve the measure, The Associated… read on > read on >
A diet rich in fish might slow the progression of multiple sclerosis in some patients, a new study says. The nutrients found in fish can quell inflammation and protect brain cells, and this might be of particular benefit for MS patients, researchers reported in the Journal of Neurology Neurosurgery & Psychiatry. MS patients who ate… read on > read on >
